GeneDx Hldgs (NASDAQ:WGS) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.01) by 2700 percent. This is a 203.7 percent decrease over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $102.300 million which missed the analyst consensus estimate of $112.956 million by 9.43 percent. This is a 17.43 percent increase over sales of $87.115 million the same period last year.